137 results
Page 2 of 7
20-F/A
bwv o03lcjrcgaul9a3
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
5207qu
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
5um2 ymhaq
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.5
xz2qqg k54yrhxxu
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
ur2oiiij6 wa
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
bua9ij
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
67801 1en0b4ee
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
vdr4mce3eklpgwzc0b1
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
vbzr3ah
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.3
p7jaz615a6iaf winig1
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
2n3o9v8zta7v68blc
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
mengzj2puai0 99k5to
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
en2234eqsy15labvxn9
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
go02q0iws w3ne5r
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.1
4zo jly85xdk75l2kms7
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
frl3 s074s3okx3c
23 Jan 19
51-102F3 Material Change Report
12:44pm